NCT00015041View on ClinicalTrials.gov

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

November 30, 1996

Primary Completion Date

June 30, 1998

Study Completion Date

July 31, 1998

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (1)

45220

Cincinnati MDRU, Cincinnati

All Listed Sponsors
collaborator

Cincinnati MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015041 - Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 | Biotech Hunter | Biotech Hunter